Biochemical reconstitution of HIV-1 assembly and maturation.
Assembly of an orthoretrovirus such as HIV-1 requires the coordinated functioning of multiple biochemical activities of the viral Gag protein. These activities include membrane targeting, lattice formation, packaging of the RNA genome, and recruitment of cellular co-factors that modulate assembly. In most previous studies, these Gag activities have been investigated individually, which have provided somewhat limited insight on how they functionally integrate during the assembly process. Here, we report the development of a biochemical reconstitution system that allowed us to investigate how Gag lattice formation, RNA binding, and the assembly factor inositol hexakisphosphate (IP6) synergize to generate immature virus particles in vitro Results identify an important rate limiting step in assembly and reveal new insights on how RNA and IP6 promote immature Gag lattice formation. The immature virus-like particles can be converted into mature capsid-like particles by simple addition of viral protease, suggesting that it is possible in principle to fully biochemically reconstitute the sequential processes of HIV-1 assembly and maturation from purified components.Importance Assembly and maturation are essential steps in the replication of orthoretroviruses such as HIV-1, and are proven therapeutic targets. These processes require the coordinated functioning of the viral Gag protein's multiple biochemical activities. We describe here the development of an experimental system that allows integrative analysis of how Gag's multiple functionalities cooperate to generate a retrovirus particle. Our current studies help to illuminate how Gag synergizes formation of the virus compartment with RNA binding, and how these activities are modulated by the small molecule, IP6. Further development and use of this system should lead to a more comprehensive understanding of the molecular mechanisms of HIV-1 assembly and maturation, and may provide new insights for the development of anti-retroviral drugs.